BioLife Solutions
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $28,466 | $27,500 | $18,785 | $28,067 |
Gross Profit | 18,287 | 17,411 | 12,677 | 17,222 |
EBITDA | 2,912 | 726 | 4,898 | 1,246 |
EBIT | 2,753 | 27 | 3,514 | -89 |
Net Income | 45,104 | 1,186 | 3,535 | 621 |
Net Change In Cash | 28,466 | 27,500 | 18,785 | 28,067 |
Free Cash Flow | 4,647 | -658 | -9,563 | 2,802 |
Cash | 23,997 | 22,822 | 33,038 | 29,481 |
Basic Shares | 49,294 | 49,248 | 48,645 | 48,723 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $96,214 | $82,254 | $75,855 | $76,239 |
Gross Profit | 62,118 | 53,671 | 46,752 | 46,911 |
EBITDA | 3,606 | 1,532 | -45,238 | -124,182 |
EBIT | -1,081 | -7,129 | -57,533 | -144,140 |
Net Income | -12,130 | -20,184 | -66,427 | -139,805 |
Net Change In Cash | 96,214 | 82,254 | 75,855 | 76,239 |
Free Cash Flow | 416 | 5,204 | -18,879 | -18,874 |
Cash | 33,038 | 95,386 | 27,896 | 19,442 |
Basic Shares | 48,645 | 46,067 | 43,719 | 42,481 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | $0.04 |
2026-03-31 | $0.04 |
2025-12-31 | $0.04 |
2025-09-30 | $0.04 |